Literature DB >> 16221509

Evaluation of a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant.

D Adams1, M Quayum, T Worthington, P Lambert, T Elliott.   

Abstract

The efficacy of a new skin disinfectant, 2% (w/v) chlorhexidine gluconate (CHG) in 70% (v/v) isopropyl alcohol (IPA) (ChloraPrep), was compared with five commonly used skin disinfectants against Staphylococcus epidermidis RP62A in the presence or absence of protein, utilizing quantitative time-kill suspension and carrier tests. All six disinfectants [70% (v/v) IPA, 0.5% (w/v) aqueous CHG, 2% (w/v) aqueous CHG, 0.5% (w/v) CHG in 70% (v/v) IPA and 10% (w/v) aqueous povidone iodine (PI)] achieved a log(10) reduction factor of 5, in colony-forming units/mL, in a suspension test (exposure time 30s) in the presence and absence of 10% human serum. Subsequent challenges of S. epidermidis RP62A in a biofilm (with and without human serum) demonstrated reduced bactericidal activity. Overall, the most effective skin disinfectants tested against S. epidermidis RP62A were 2% (w/v) CHG in 70% IPA and 10% (w/v) PI. These results suggest that enhanced skin antisepsis may be achieved with 2% (w/v) CHG in 70% (v/v) IPA compared with the three commonly used CHG preparations [0.5% (w/v) aqueous CHG, 2% (w/v) aqueous CHG and 0.5% (w/v) CHG in 70% (v/v) IPA].

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16221509     DOI: 10.1016/j.jhin.2005.05.015

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  20 in total

1.  Penetration of chlorhexidine into human skin.

Authors:  T J Karpanen; T Worthington; B R Conway; A C Hilton; T S J Elliott; P A Lambert
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

2.  Permeation of chlorhexidine from alcoholic and aqueous solutions within excised human skin.

Authors:  T J Karpanen; T Worthington; B R Conway; A C Hilton; T S J Elliott; P A Lambert
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

3.  Procedure for Horizontal Transfer of Patient-Derived Xenograft Tumors to Eliminate Corynebacterium bovis.

Authors:  Christopher A Manuel; Stacey M Bagby; Julie A Reisinger; Umarani Pugazhenthi; Todd M Pitts; Stephen B Keysar; John J Arcaroli; Jori K Leszczynski
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-03-01       Impact factor: 1.232

4.  Reduction of central line-associated bloodstream infection rates in a neonatal intensive care unit after implementation of a multidisciplinary evidence-based quality improvement collaborative: A four-year surveillance.

Authors:  Joseph Y Ting; Vicki Sk Goh; Horacio Osiovich
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 5.  Antiseptic use in the neonatal intensive care unit - a dilemma in clinical practice: An evidence based review.

Authors:  Sundar Sathiyamurthy; Jayanta Banerjee; Sunit V Godambe
Journal:  World J Clin Pediatr       Date:  2016-05-08

Review 6.  Microneedle-based vaccines.

Authors:  Mark R Prausnitz; John A Mikszta; Michel Cormier; Alexander K Andrianov
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

7.  Alcohols for skin antisepsis at clinically relevant skin sites.

Authors:  Mirja Reichel; Peter Heisig; Thomas Kohlmann; Günter Kampf
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

Review 8.  Basic Principles of Disinfection and Sterilization in Intensive Care and Anesthesia and Their Applications during COVID-19 Pandemic.

Authors:  Amol T Kothekar; Atul P Kulkarni
Journal:  Indian J Crit Care Med       Date:  2020-11

9.  Pitfalls in efficacy testing--how important is the validation of neutralization of chlorhexidine digluconate?

Authors:  Mirja Reichel; Peter Heisig; Günter Kampf
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-12-02       Impact factor: 3.944

10.  A prospective randomised trial to compare the efficacy of povidone-iodine 10% and chlorhexidine 2% for skin disinfection.

Authors:  Atul P Kulkarni; Rishikesh M Awode
Journal:  Indian J Anaesth       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.